CYP 450 enzyme induction by chronic oral musk xylene in adult and developing rats

Toxicology Letters

Volumn 111, Issue 1-2, 1999, Pages 117-132

  Suter Eichenberger, R ^a   Boelsterli, U A ^b   Conscience Egli, M ^a   Lichtensteiger, W ^a   Schlumpf, M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Cytochrome P450 1A; Cytochrome P450 2B; Cytochrome P450 3A; Developmental adult toxicity; Enzyme induction; Musk xylene

Indexed keywords

CYTOCHROME P450; MUSK XYLENE;

ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ADMINISTRATION, ORAL; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; FEMALE; FETUS; MALE; PERFUME; PREGNANCY; RATS; RATS, LONG-EVANS; WATER POLLUTANTS, CHEMICAL; XYLENES;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0032708616     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00173-3     Document Type: Article

References (43)

1. Arlotto M.P., Sonderfan A.J., Klaassen C.D., Parkinson A. Studies on the pregnenolone-16-carbonitrile-inducible form of rat liver microsomal cytochrome P-450 and UDP-glucuronosyltransferase. Biochem. Pharmacol. 36(22):1987;3859-3866.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Brunn H., Rimkus G. Synthetische Moschusduftstoffe - Anwendung, Anreicherung in der Umwelt und Toxikologie (2. Teil). Ern. -Umschau. 44(1):1997;4-9.
4. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haaparanta T., Mayer R.T. Ethoxy-, pentoxy-and benzyloxypenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34(18):1985;3337-3345.
5. Cooper K.O., Reik L.M., Jayyosi Z., Bandiera S., Kelley M., Ryan D.E., Daniel R., McCluskey S.A., Levin W., Thomas P.E. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch. Biochem. Biophys. 301(2):1993;345-354.
6. Cresteil T. Regulation of drug-metabolizing enzymes during the perinatal period in rat and human liver. Bioessays. 7(3):1987;120-124.
7. Cresteil T., Beaune P., Celier C., Leroux J.P., Guengerich F.P. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene. J. Pharmacol. Exp. Ther. 236(1):1986;269-276.
8. Ford R.A. The safety of nitromusks in fragrances - a review. Dtsch. Lebensm.-rundsch. 94(6):1998;192-200.
9. Gatermann R., Hühnerfuss H., Rimkus G., Kettrup A. Occurrence of musk xylene and musk ketone metabolites in the aquatic environment. Chemosphere. 36(11):1998;2535-2547.
10. Giachelli C.M., Omiecinski C.J. Regulation of cytochrome P-450b and P-450e mRNA expression in the developing rat. J. Biol. Chem. 261(3):1986;1359-1363.
11. Gonzales F.J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 40(4):1989;243-286.
12. Guenthner T.M, Mannering G.J. Induction of hepatic mono-oxygenase systems in fetal and neonatal rats with phenobarbital, polycyclic hydrocarbons and other xenobiotics. Biochem. Pharmacol. 26:1977;567-575.
13. He J-S., Fulco A.J. A barbiturate-regulated protein binding to a common sequence in the cytochrome P450 genes of rodents and bacteria. J. Biol. Chem. 266:1991;7864-7869.
14. Helbich, H.-M., 1995. Gaschromatographisch-massenspektrometrische Untersuchungen zur Analytik und zum Vorkommen von mono- und non-ortho-koplanaren PCB-Kongeneren sowie Moschus Xylol im Fettgewebe von Kindern. Inaugural-Dissertation, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg.
15. Ippen H. Nitro musks. Int. Arch. Occup. Environ. Health. 66:1994;283-285.
16. Iwata N., Minegishi K., Suzuki K., Ohno Y., Kawanishi T., Takahashi A. Musk xylene is a novel specific inducer of cytochrome P-450IA2. Biochem. Biophys. Res. Commun. 184(1):1992;149-153.
17. Iwata N., Minegishi K.-I., Suzuki K., Ohno Y., Igarashi T., Satoh T., Takahashi A. An unusual profile of musk xylene-induced drug-metabolizing enzymes in rat liver. Biochem. Pharmacol. 45(8):1993;1659-1665.
18. Iwata N., Minegishi K., Suzuki K., Ohno Y., Igarashi T., Satoh T., Takahashi A. An unusual profile of musk xylene-induced drug-metabolizing enzymes in rat liver. Biochem. Pharmacol. 45:1993;1659-1665.
19. Iwata N., Suzuki K., Minegishi K., Kawanishi T., Hara S., Endo T., Takahashi A. Induction of cytochrome P450 IA2 by musk analogues and other inducing agents in rat liver. Eur. J. Pharmacol. 248:1993;243-250.
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Lake, B.G., 1987. Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In: Suell, K., Mullock, B. (Eds.), Biochemical Toxicology, A Practical Approach, IRL Press, pp. 183-214.
22. Leakey J.E.A., Fouts J.R. Precocious development of cytochrome P-450 in neonatal rat liver after glucocorticoid treatment. Biochem. J. 182:1979;233-235.
23. Lehman-McKeeman L.D., Caudill D., Young J.A., Dierckman T.A. Musk xylene induces and inhibits mouse hepatic cytochrome P-450 2B enzymes. Biochem. Biophys. Res. Commun. 206(3):1995;975-980.
24. Lehman-McKeeman L.D., Johnson D.R., Caudill D. Induction and inhibition of mouse cytochrome P-450 2B enzymes by musk xylene. Toxicol. Appl. Pharmacol. 142:1997;169-177.
25. Lehman-McKeeman L.D., Johnson D.R., Caudill D., Stuard S.B. Mechanism-based inactivation of mouse hepatic cytochrome P450 2B enzymes by amine metabolites of musk xylene. Drug Metab. Dispos. 25(3):1997;384-389.
26. Lehman-McKeeman L.D., Stuard S.B., Caudill D., Johnson D.R. Induction of mouse cytochrome P450 2B enzymes by amine metabolites of musk xylene: contribution of microsomal enzyme induction to the hepatocarcinogenicity of musk xylene. Mol. Carcinog. 20:1997;308-316.
27. Liebl B., Ehrenstorfer S. Nitro musks in human milk. Chemosphere. 27(11):1993;2253-2260.
28. Lubet R.A, Dragnev K.H, Chauhan D.P., Nims R.W., Diwan B.A., Ward J.M., Jones C.R., Rice J.M., Miller M.S A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Biochem. Pharmacol. 43(5):1992;1067-1078.
29. Lubet R.A., Guengerich F.P., Nims R.W. The induction of alkoxyresorufin metabolism: A potential indicator of environmental contamination. Arch. Environ. Contam. Toxicol. 19:1990;157-163.
30. Maekawa A., Matsushima Y., Onodera H., Shibutani H., Ogasawara H., Kodama Y., Kurokawa Y., Hayashi Y. Long-term toxicity/carcinogenicity of musk xylol in B6C3F1 mice. Fd. Chem. Toxic. 28(8):1990;581-586.
31. Mersch-Sundermann V., Reinhardt A., Emig M. Untersuchungen zu Mutagenität, Genotoxizität und Kogenotoxizität umweltrelevanter Nitromoschusverbindungen. Zbl. Hyg. 198:1996;429-442.
32. Minegishi K., Nambaru S., Fukuoka M., Tanaka A., Mogami T.N. Distribution, metabolism, and excretion of musk xylene in rats. Arch. Toxicol. 65:1991;273-282.
33. Müller S., Schmid P., Schlatter C. Occurrence of nitro and non-nitro benzenoid musk compounds in human adipose tissue. Chemosphere. 33(1):1996;17-28.
34. Namkung M.J., Yang H.L., Hulla J.E., Juchau M.R. On the substrate specificity of cytochrome P450IIIA1. Mol. Pharmacol. 34:1988;628-637.
35. Nerurkar P.V., Park S.S., Thomas P.E., Nims R.W., Lubet R.A. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmacol. 46(5):1993;933-943.
36. Rimkus G., Brunn H. Synthetische Moschusduftstoffe-Anwendung, Anreicherung in der Umwelt und Toxikologie (1. Teil). Ern.-Umschau. 43(12):1996;442-449.
37. Rimkus G., Rimkus B., Wolf M. Nitro musks in human adipose tissue and breast milk. Chemosphere. 28(2):1994;421-432.
38. Rimkus G., Wolf M. Nachweis von Nitromoschusverbindungen in Frauenmilch und Humanfett. Dtsch. Lebensm.-rundsch. 89(4):1993;103-107.
39. Rowland I.R. Reduction by the gut microflora of animals and man. Biochem. Pharmacol. 35(1):1986;27-32.
40. Rowland J.R., Mallet A.K, Wise A. The effect of diet on mammalian gut flora and its metabolic activities. CRC Crit. Rev. Toxicol. 16:1985;31-103.
41. Suter-Eichenberger R., Altorfer H., Lichtensteiger W., Schlumpf M. Bioaccumulation of musk xylene (MX) in developing and adult rats of both sexes. Chemosphere. 36(13):1998;2747-2762.
42. Watkins P.B. Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin. Liver Dis. 10(4):1990;235-249.
43. Wisneski H.S., Havery D.C. Nitro musks in fragrance products: an update of FDA findings. Cosmet. Toiletries. 111:1996;73-76.